Patients having oxycodone should be monitored or cautioned when commencing a new medication That could be a known CYP450 inhibitor. Inhibition of those enzymes can lead to possibly lethal oxycodone concentrations in the blood.[eighteen] On top of that, this medication shouldn't be abruptly discontinued in clients who might be opioid-dependent, as